InsiderTrades

Form 4 for KVYO Klaviyo, Inc.

Accepted 2024-08-16 00:00:00 ET · period of report 2024-08-15 · accession 0001835830-24-000086 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-08-16 2024-08-15+ KVYO Rowland Stephen Eric Pres C - Cnv Deriv — +110.1K 210.6K +110% —
D 2024-08-16 2024-08-15 KVYO Rowland Stephen Eric Pres F - Tax $31.83 -97.7K 192.5K -34% -$3.11M
D 2024-08-16 2024-08-16 KVYO Rowland Stephen Eric Pres S - Sale $31.67 -18.1K 192.5K -9% -$573.7K
DM 2024-08-16 2024-08-15+ KVYO Rowland Stephen Eric Pres C - Cnv Deriv $0.00 -110.1K 729.0K -13% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Series A Common Stock 2024-08-15 C A 92,033 — 290,236 D — — (F2) Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock, and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date.
2 Common Series A Common Stock 2024-08-16 C A 18,114 — 210,602 D — — (F2) Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock, and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date.
3 Common Series A Common Stock 2024-08-15 F D 97,748 $31.83 192,488 D — —
4 Common Series A Common Stock 2024-08-16 S D 18,114 $31.67 192,488 D — — (F5) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.42 to $31.82 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F6) Consists of (i) 14,059 shares of Series A Common Stock and (ii) 178,429 unvested RSUs awarded under the Issuer's 2023 Stock Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement.
5 Derivative Series B Common Stock 2024-08-16 C D 18,114 $0.00 710,843 D — · — to — 18,114 Series A Common Stock (F7) Consists of (i) 95,100 shares of Series B Common Stock and (ii) 615,743 unvested RSUs awarded under the Issuer's 2015 Stock Incentive Plan, each representing the contingent right to receive one share of Series B Common Stock upon vesting and settlement. (F2) Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock, and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date.
6 Derivative Series B Common Stock 2024-08-15 C D 92,033 $0.00 728,957 D — · — to — 92,033 Series A Common Stock (F2) Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock, and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date.